https://retacompare.com/news/examining-the-safety-of-glp-1-agonists-for-obese-adolescents 2026-10-26T13:57:41.000Z RetatrutideCompare en 2026-10-26T13:57:41.000Z Examining the Safety of GLP-1 Agonists for Obese Adolescents Clinical Trials, Retatrutide https://retacompare.com/news/latest-developments-in-glp-1-agonists-and-retatrutide-research 2026-10-26T09:10:15.000Z RetatrutideCompare en 2026-10-26T09:10:15.000Z Latest Developments in GLP-1 Agonists and Retatrutide Research Market News, Retatrutide https://retacompare.com/news/latest-developments-in-glp-1-agonists-for-obesity-treatment 2026-10-26T03:11:12.000Z RetatrutideCompare en 2026-10-26T03:11:12.000Z Latest Developments in GLP-1 Agonists for Obesity Treatment Market News, Retatrutide https://retacompare.com/news/potential-impact-of-glp-1-drugs-on-crohn-s-and-ulcerative-colitis-explored 2026-10-26T03:00:48.000Z RetatrutideCompare en 2026-10-26T03:00:48.000Z Potential Impact of GLP-1 Drugs on Crohn's and Ulcerative Colitis Explored Clinical Trials, Retatrutide https://retacompare.com/news/exploring-adult-weight-loss-drugs-for-pediatric-obesity-treatment 2026-10-26T02:49:41.368Z RetatrutideCompare en 2026-10-26T02:49:41.368Z Exploring Adult Weight-Loss Drugs for Pediatric Obesity Treatment Weight Loss, Retatrutide https://retacompare.com/news/eli-lilly-s-retatrutide-advances-in-weight-loss-drug-development-2 2026-10-25T22:36:24.000Z RetatrutideCompare en 2026-10-25T22:36:24.000Z Eli Lilly's Retatrutide Advances in Weight Loss Drug Development Weight Loss, Retatrutide https://retacompare.com/news/comparing-weight-loss-drugs-tirzepatide-semaglutide-and-retatrutide 2026-10-25T21:52:16.000Z RetatrutideCompare en 2026-10-25T21:52:16.000Z Comparing Weight Loss Drugs: Tirzepatide, Semaglutide, and Retatrutide Market News, Retatrutide https://retacompare.com/news/eli-lilly-s-retatrutide-advances-in-weight-loss-drug-development 2026-10-25T21:01:34.000Z RetatrutideCompare en 2026-10-25T21:01:34.000Z Eli Lilly's Retatrutide Advances in Weight Loss Drug Development Weight Loss, Retatrutide https://retacompare.com/news/retatrutide-new-developments-in-glp-1-agonist-obesity-treatments 2026-10-25T20:35:04.000Z RetatrutideCompare en 2026-10-25T20:35:04.000Z Retatrutide: New Developments in GLP-1 Agonist Obesity Treatments Weight Loss, Retatrutide https://retacompare.com/news/recent-developments-in-glp-1-agonists-and-retatrutide-highlighted 2026-10-25T20:03:43.000Z RetatrutideCompare en 2026-10-25T20:03:43.000Z Recent Developments in GLP-1 Agonists and Retatrutide Highlighted Market News, Retatrutide https://retacompare.com/news/eli-lilly-s-retatrutide-shows-promising-weight-loss-results 2026-10-25T13:28:45.000Z RetatrutideCompare en 2026-10-25T13:28:45.000Z Eli Lilly's Retatrutide Shows Promising Weight Loss Results Weight Loss, Retatrutide https://retacompare.com/news/retatrutide-advances-in-glp-1-obesity-drug-research-for-2025 2026-10-25T13:10:59.000Z RetatrutideCompare en 2026-10-25T13:10:59.000Z Retatrutide Advances in GLP-1 Obesity Drug Research for 2025 Market News, Retatrutide https://retacompare.com/news/retatrutide-and-glp-1-agonists-influence-weight-loss-drug-market 2026-10-25T10:08:45.000Z RetatrutideCompare en 2026-10-25T10:08:45.000Z Retatrutide and GLP-1 Agonists Influence Weight Loss Drug Market Market News, Retatrutide https://retacompare.com/news/advancements-in-glp-1-obesity-drugs-highlight-retatrutide-s-potential 2026-10-25T03:12:05.000Z RetatrutideCompare en 2026-10-25T03:12:05.000Z Advancements in GLP-1 Obesity Drugs Highlight Retatrutide's Potential Market News, Retatrutide https://retacompare.com/news/chemical-analysis-of-unofficial-retatrutide-raises-concerns 2026-10-24T15:55:00.000Z RetatrutideCompare en 2026-10-24T15:55:00.000Z Chemical Analysis of Unofficial Retatrutide Raises Concerns Market News, Retatrutide